Apontis Pharma AG Capital Reinvestment Ratio
Apontis Pharma AG capital reinvestment ratio. Apontis Pharma AG (APPH) has a Capital Reinvestment Ratio of 0.01x as of December 2024, meaning it reinvests 0% of its operating cash flow (€905.24K) in capital expenditures (€5.60K). Check Apontis Pharma AG cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Apontis Pharma AG (2020–2022)
Capital reinvestment ratio of Apontis Pharma AG from 2020 to 2022. This chart tracks Apontis Pharma AG's Capital Reinvestment Ratio across 3 annual periods. Also explore APPH net assets growth trend to track the company's year-over-year net asset growth rate.
Apontis Pharma AG Capital Reinvestment Ratio by Year (2020–2022)
Apontis Pharma AG capital reinvestment ratio by year from 2020 to 2022. For the full cash flow conversion analysis, see APPH operating cash flow.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.30x | €11.02 Million | €3.28 Million | ▼ -38.5% |
| 2021 | 0.48x | €3.43 Million | €1.66 Million | ▼ -3.8% |
| 2020 | 0.50x | €1.45 Million | €729.56K | — |